|
1
|
Oxysterols direct B-cell migration through EBI2.
|
Nature
|
2011
|
1.94
|
|
2
|
Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain.
|
J Neurosci
|
2003
|
1.88
|
|
3
|
Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81.
|
J Biol Chem
|
2008
|
1.75
|
|
4
|
Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135.
|
J Biol Chem
|
2003
|
1.39
|
|
5
|
Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1.
|
Mol Pharmacol
|
2005
|
1.32
|
|
6
|
Identification of relaxin-3/INSL7 as a ligand for GPCR142.
|
J Biol Chem
|
2003
|
1.19
|
|
7
|
INSL5 is a high affinity specific agonist for GPCR142 (GPR100).
|
J Biol Chem
|
2004
|
1.12
|
|
8
|
A novel form of neurotensin post-translationally modified by arginylation.
|
J Biol Chem
|
2005
|
1.01
|
|
9
|
Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus.
|
Learn Mem
|
2009
|
0.98
|
|
10
|
Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing.
|
Neuroendocrinology
|
2005
|
0.95
|
|
11
|
Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
|
Mol Pharmacol
|
2004
|
0.94
|
|
12
|
3,5-Dihydroxybenzoic acid, a specific agonist for hydroxycarboxylic acid 1, inhibits lipolysis in adipocytes.
|
J Pharmacol Exp Ther
|
2012
|
0.92
|
|
13
|
Pharmacological characterization of relaxin-3/INSL7 receptors GPCR135 and GPCR142 from different mammalian species.
|
J Pharmacol Exp Ther
|
2004
|
0.86
|
|
14
|
Identification of structural motifs critical for epstein-barr virus-induced molecule 2 function and homology modeling of the ligand docking site.
|
Mol Pharmacol
|
2012
|
0.86
|
|
15
|
Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.
|
Ann N Y Acad Sci
|
2009
|
0.82
|
|
16
|
G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
|
Neuroendocrinology
|
2006
|
0.79
|
|
17
|
Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135).
|
Eur J Pharmacol
|
2008
|
0.77
|
|
18
|
Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dog.
|
Eur J Pharmacol
|
2005
|
0.77
|
|
19
|
Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
|
Ann N Y Acad Sci
|
2009
|
0.76
|
|
20
|
Recent progress in relaxin-3-related research.
|
Ann N Y Acad Sci
|
2005
|
0.75
|